Trial intelligence / Profile preview

Dexmedetomidine for postoperative pain in thoracic surgery

NCT01973452Phase 3Completed

Sponsor
Memorial Sloan Kettering Cancer Center
Start
Oct 2013
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dexmedetomidine in postoperative pain, sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 2013; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01973452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01973452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call